PFSA Profusa, Inc.

NEUTRAL Impact: 2/10 PRESS-RELEASE
Horizon months Filed Jun 12, 2026 Processed 2d 22h ago Wire GlobeNewswire
Press release: announcement

Price Chart

Loading chart...

Executive Summary

Profusa announced submission of its response package to European Notified Body GMED for CE Mark certification of the Lumee Oxygen Platform. This is a procedural regulatory milestone with no financial data or assurance of outcome.

Actionable Insight

Monitor for CE Mark approval decision or further regulatory updates; no immediate catalyst from this procedural filing.

Key Facts

  • Profusa submitted response package to GMED for CE Mark conformity assessment of the Lumee Oxygen Platform
  • No financial figures, guidance, or approval timeline disclosed
  • CE Mark review process remains ongoing with no assurance of timing or outcome

Financial Impact

No financial impact disclosed; regulatory step with uncertain commercial outcome

Risk Factors

  • CE Mark approval not guaranteed and timing uncertain
  • Company has $1M market cap and negative historical stock performance following prior filings

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3311009
5 reports for PFSA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PFSA — sortable, filterable
Type Now
Jun 12, 2026
2d ago
Press Release
NEUTRAL ★ 2/10
$0.2729 awaiting T+5awaiting T+5$0.2240 (−17.92%)
May 15, 2026
4w ago
Press Release
NEUTRAL ★ 4/10
$0.4450 $0.3760▼ −15.51%▼ −16.47%$0.2240 (−49.66%)
May 4, 2026
6w ago
Insider Cluster
MIXED ★ 6/10
$0.5570 $0.4800▼ −13.82%▼ −16.76%$0.2240 (−59.78%)
Mar 13, 2026
13w ago
8-K
BEARISH ★ 8/10
$0.9170 $0.5270▲ +42.53%▲ +40.41%$0.2240 (+75.57%)
Mar 4, 2026
14w ago
EFFECT
NEUTRAL ★ 4/10
$0.9990 $0.9280▼ −7.11%▼ −5.77%$0.2240 (−77.58%)
Showing 5 of 5

US Market Status

Market Closed — Opens in 2h 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access